| Dr Edward L Friedland, MD | |
|
1619 Creighton Rd Ste 1, Pensacola, FL 32504-7152 | |
| (850) 444-4700 | |
| (850) 434-8144 |
| Full Name | Dr Edward L Friedland |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 43 Years |
| Location | 1619 Creighton Rd Ste 1, Pensacola, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649273327 | NPI | - | NPPES |
| ME76760 | Other | FL | FLORIDA MEDICAL LICENSURE |
| 256009700 | Medicaid | FL | |
| 390006485 | Other | FL | RAILROAD MEDICARE |
| MD.22503 | Other | AL | ALABAMA MEDICAL LICENSURE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | MD.22503 (Alabama) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | ME76760 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc - Pensacola | Pensacola, FL | Dialysis facility |
| Rcg - Baptist North | Pensacola, FL | Dialysis facility |
| Fmc - West Pensacola | Pensacola, FL | Dialysis facility |
| Dialyze Direct Fl | Boca raton, FL | Dialysis facility |
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| Baptist Hospital | Pensacola, FL | Hospital |
| West Florida Hospital | Pensacola, FL | Hospital |
| Gulf Breeze Hospital | Gulf breeze, FL | Hospital |
| South Baldwin Regional Medical Center | Foley, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fresenius Vascular Care Pensacola Llc | 0547549263 | 5 |
| Pensacola Nephrology Pa | 7214832856 | 30 |
| Pensacola Nephrology Pa | 7214832856 | 30 |
News Archive
Life Technologies Corporation and BGI (formerly Beijing Genomics Institute) announced today that they have partnered to offer whole human genome resequencing on the SOLiD™ 4 System. BGI, one of the world's largest genomic centers, has acquired 27 SOLiD 4 Systems, which will allow BGI to deliver 50 whole human genome sequences a month.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
One in ten NHS patients comes to harm while in hospital as a result of their clinical care, suggests a study in Quality and Safety in Health Care.
Popular sideline vision tests used to help detect immediate signs of concussion may present challenges in the interpretation of results for athletes who speak English as a second language (ESL).
› Verified 5 days ago
| Entity Name | Pensacola Nephrology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518969765 PECOS PAC ID: 7214832856 Enrollment ID: O20040429001260 |
News Archive
Life Technologies Corporation and BGI (formerly Beijing Genomics Institute) announced today that they have partnered to offer whole human genome resequencing on the SOLiD™ 4 System. BGI, one of the world's largest genomic centers, has acquired 27 SOLiD 4 Systems, which will allow BGI to deliver 50 whole human genome sequences a month.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
One in ten NHS patients comes to harm while in hospital as a result of their clinical care, suggests a study in Quality and Safety in Health Care.
Popular sideline vision tests used to help detect immediate signs of concussion may present challenges in the interpretation of results for athletes who speak English as a second language (ESL).
› Verified 5 days ago
| Entity Name | Fresenius Vascular Care Pensacola Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285031963 PECOS PAC ID: 0547549263 Enrollment ID: O20161119000176 |
News Archive
Life Technologies Corporation and BGI (formerly Beijing Genomics Institute) announced today that they have partnered to offer whole human genome resequencing on the SOLiD™ 4 System. BGI, one of the world's largest genomic centers, has acquired 27 SOLiD 4 Systems, which will allow BGI to deliver 50 whole human genome sequences a month.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
One in ten NHS patients comes to harm while in hospital as a result of their clinical care, suggests a study in Quality and Safety in Health Care.
Popular sideline vision tests used to help detect immediate signs of concussion may present challenges in the interpretation of results for athletes who speak English as a second language (ESL).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward L Friedland, MD Po Box 11037, Pensacola, FL 32524-1037 Ph: (850) 444-4700 | Dr Edward L Friedland, MD 1619 Creighton Rd Ste 1, Pensacola, FL 32504-7152 Ph: (850) 444-4700 |
News Archive
Life Technologies Corporation and BGI (formerly Beijing Genomics Institute) announced today that they have partnered to offer whole human genome resequencing on the SOLiD™ 4 System. BGI, one of the world's largest genomic centers, has acquired 27 SOLiD 4 Systems, which will allow BGI to deliver 50 whole human genome sequences a month.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
One in ten NHS patients comes to harm while in hospital as a result of their clinical care, suggests a study in Quality and Safety in Health Care.
Popular sideline vision tests used to help detect immediate signs of concussion may present challenges in the interpretation of results for athletes who speak English as a second language (ESL).
› Verified 5 days ago
Mohamed K Helmi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5149 N. 9th Ave., Suite 120, Pensacola, FL 32504 Phone: 850-477-9253 Fax: 850-494-9843 | |
Dr. Peter A Marco, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5149 N. 9th Avenue, Suite 120, Pensacola, FL 32504 Phone: 850-477-9253 Fax: 850-494-9843 | |
Dr. Paul T Castro, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8383 N Davis Hwy, West Florida Hospital, Pensacola, FL 32514 Phone: 850-494-5403 Fax: 850-494-4382 | |
Alejandro A Inclan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4724 N Davis Hwy, Pensacola, FL 32503 Phone: 850-696-4000 Fax: 850-444-7057 | |
Dr. Samual Wade Sauer, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4451 Bayou Blvd, Pensacola, FL 32503 Phone: 850-416-7619 Fax: 850-416-7753 | |
Dr. Robert E Bondurant, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 10095 Hillview Dr, Pensacola, FL 32514 Phone: 850-479-4000 Fax: 850-479-4034 | |
Dr. Edgar Antonio Gonzalez, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 6000 W Highway 98, Pensacola Naval Hospital, Pensacola, FL 32512 Phone: 850-515-7171 |